Related Experiment Video
Updated: Jul 15, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Maternal antibodies in breast milk protect the child from enterovirus infections
Karita Sadeharju1, Mikael Knip, Suvi M Virtanen
1Department of Virology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Insights
Breastfeeding protects infants from enterovirus infections. Maternal antibodies in breast milk are key to this protective effect, reducing infection rates in infants who are breastfed for longer durations.
Area of Science:
- Immunology
- Pediatrics
- Virology
Background:
- Enterovirus infections pose significant risks to infants, potentially leading to severe health complications.
- Understanding protective mechanisms against these common viral infections is crucial for infant health.
Purpose of the Study:
- To investigate the protective role of breastfeeding against enterovirus infections in infants.
- To determine if maternal antibodies in breast milk or infant circulation contribute to this protection.
Main Methods:
- Prospective follow-up of 150 infants from birth, monitoring for enterovirus infections.
- Collection of maternal breast milk and blood samples at 3-month intervals for antibody and RNA analysis.
- Recording breastfeeding duration and analyzing maternal serum from pregnancy through postpartum.
Main Results:
- Enterovirus infections occurred in 43% of infants by age one; 15% of mothers were infected during pregnancy.
- Infants exclusively breastfed for over two weeks experienced fewer enterovirus infections compared to those breastfed for two weeks or less.
- Elevated maternal antibody levels in serum and breast milk correlated with reduced infection frequency, specifically in infants breastfed longer than two weeks.
Conclusions:
- Breastfeeding demonstrates a significant protective effect against enterovirus infections during infancy.
- The primary mechanism for this protection appears to be the transfer of maternal antibodies present in breast milk.
Objective:
Enterovirus infections are frequent in infants and may cause severe complications. We set out to assess whether breastfeeding can protect against these infections and whether such an effect is related to maternal antibodies in breast milk or in the peripheral circulation of the infant.
Methods:
One hundred fifty infants who were prospectively followed up from birth were monitored for enterovirus infections. The duration of breastfeeding was recorded, and maternal breast milk and blood samples were regularly taken at 3-month intervals for the detection of enterovirus antibodies and RNA. Maternal serum was available from early pregnancy, delivery, and 3 months postpartum.
Results:
Enterovirus infections were frequent and were diagnosed in 43% of infants before the age of 1 year and in 15% of the mothers during pregnancy. Infants exclusively breastfed for >2 weeks had fewer enterovirus infections by the age of 1 year compared with those exclusively breastfed for < or =2 weeks (0.38 vs 0.59 infections per child). High maternal antibody levels in serum and in breast milk were associated with a reduced frequency of infections. This effect was seen only in those infants breastfed >2 weeks, indicating that breast milk antibodies mediate this effect. Enterovirus RNA was not found in any of the breast milk samples.
Conclusions:
These results suggest that breastfeeding has a protective effect against enterovirus infections in infancy. This effect seems to be mediated primarily by maternal antibodies in breast milk.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Respiratory Syncytial Virus Disease
Poliomyelitis
Vaccinations
Development of Human Microbiota
Cytomegalovirus Disease

